Ray Co

Ray Co EBIT Margin

The EBIT Margin (Operating Margin) of Ray Co (228670.KQ) as of Nov 18, 2026 is -8.79 %. In the previous year, EBIT Margin (Operating Margin) was -60.57 % — a change of -85.48% (higher).

EBIT Margin

-8.79 %

YoY

-85.48%

Last updated:

EBIT Margin (Operating Margin) of Ray Co is 2025 -8.79 % . EBIT Margin (Operating Margin) of Ray Co was 2024 -60.57 % . It decreases by -85.48% higher compared to the previous year.

For Ray Co, the operating (EBIT) margin of -8.8% is down versus 1.2% a few years ago.

The Ray Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
11.74 KRW
Jan 1, 2019
17.59 KRW
Jan 1, 2020
8.30 KRW
Jan 1, 2021
1.19 KRW
Jan 1, 2022
12.56 KRW
Jan 1, 2023
1.26 KRW
Jan 1, 2024
-60.57 KRW
Jan 1, 2025
-8.79 KRW
The Ray Co EBIT Margin history
YEAREBIT MarginYoY
-8.79 %-85.48%
-60.57 %-4,914.03%
1.26 %-89.99%
12.56 %+951.58%
1.19 %-85.60%
8.30 %-52.83%
17.59 %+49.90%
11.74 %+98.59%
5.91 %+18.19%
5.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ray Co Stock analysis

What does Ray Co do? Ray Co., Ltd. generates revenue through the manufacturing and sale of advanced technology medical devices, focusing on digital diagnostic systems and digital therapy solutions. The company produces dental radiography equipment such as x-ray systems and cone beam computed tomography (CBCT) systems, alongside 3D scanning, dental computer aided design (CAD), and 3D printers for prosthodontics, orthodontics, and implant surgery. Domestic and overseas markets purchase these products, with the company operating through subsidiaries to distribute its offerings globally. Digital diagnostic systems like dental radiography equipment and CBCT systems are sold to healthcare providers and dental clinics, while digital therapy solutions including 3D scanning and CAD systems target dental laboratories and surgical centers. The firm's product portfolio serves both domestic and international clients, leveraging its subsidiaries for global distribution channels. Ray Co., Ltd. emphasizes advanced technology in its medical device offerings, with digital therapy solutions such as 3D printers and CAD systems being key revenue drivers. The company's focus on dental-specific applications ensures targeted sales to specialized healthcare segments, including prosthodontics, orthodontics, and implant surgery practices. Ray Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ray Co stock

EBIT Margin (Operating Margin) of Ray Co is -8.79 % in 2025.

EBIT Margin (Operating Margin) of Ray Co changed from -60.57 % to -8.79 %, representing a -85.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Ray Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Ray Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Ray Co

All Key Metrics — Ray Co